Hi there,

May 1 and 2 are Public Media Giving Days. With lies and disinformation flooding the media landscape, and the Trump administration increasing its attacks on journalists, the need for independent news questioning and challenging those in power is more critical now than ever. We do not take any government or corporate funding, so we can remain unwavering in our commitment to bring you fearless trustworthy reporting on the issues that matter most. Thanks to a group of generous donors, all donations made today will be DOUBLED, which means your $15 gift is worth $30. If our journalism is important to you, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!

Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Protesters Demand Pfizer End Pandemic Profiteering and Share Vaccine Technologies

HeadlineApr 29, 2022

In London, advocates for a “people’s vaccine” rallied outside Pfizer’s U.K. headquarters Thursday, demanding the drugmaker end pandemic profiteering and share its vaccine technology with the Global South. Activists carried signs reading “Pharma greed kills” and “Pfizer has blood on its hands,” as they delivered wheelbarrows full of fake cash to the entrance of the building. Pfizer’s COVID-19 vaccine is one of the most lucrative pharmaceutical products in history, earning the company some $37 billion last year alone — or over $1,000 a second. In a statement, the group Global Justice Now responded, “This is scandalous when more than 8 in 10 people in low-income countries still haven’t had a Covid-19 vaccine.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top